These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30350751)

  • 41. Clinical features and prognostic factors in patients with head and neck cancer: Results from a multicentric study.
    Leoncini E; Vukovic V; Cadoni G; Pastorino R; Arzani D; Bosetti C; Canova C; Garavello W; La Vecchia C; Maule M; Petrelli L; Pira E; Polesel J; Richiardi L; Serraino D; Simonato L; Ricciardi W; Boccia S
    Cancer Epidemiol; 2015 Jun; 39(3):367-74. PubMed ID: 25770642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age is an independent poor prognostic factor in cutaneous head and neck melanoma.
    Stokes WA; Lentsch EJ
    Laryngoscope; 2014 Feb; 124(2):462-5. PubMed ID: 23881555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
    Jung YS; Lim J; Jung KW; Ryu J; Won YJ
    PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trends in net survival from head and neck cancer in six European Latin countries: results from the SUDCAN population-based study.
    Guizard AV; Uhry Z; de Raucourt D; Mazzoleni G; Sánchez MJ; Ligier K;
    Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S16-S23. PubMed ID: 28005601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trends in epidemiology and treatment and outcome for head and neck cancer: a population-based long-term analysis from 1996 to 2011 of the Thuringian cancer registry.
    Guntinas-Lichius O; Wendt TG; Kornetzky N; Buentzel J; Esser D; Böger D; Müller A; Schultze-Mosgau S; Schlattmann P; Schmalenberg H
    Oral Oncol; 2014 Dec; 50(12):1157-64. PubMed ID: 25459063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.
    Negri E; Boffetta P; Berthiller J; Castellsague X; Curado MP; Dal Maso L; Daudt AW; Fabianova E; Fernandez L; Wünsch-Filho V; Franceschi S; Hayes RB; Herrero R; Koifman S; Lazarus P; Lence JJ; Levi F; Mates D; Matos E; Menezes A; Muscat J; Eluf-Neto J; Olshan AF; Rudnai P; Shangina O; Sturgis EM; Szeszenia-Dabrowska N; Talamini R; Wei Q; Winn DM; Zaridze D; Lissowska J; Zhang ZF; Ferro G; Brennan P; La Vecchia C; Hashibe M
    Int J Cancer; 2009 Jan; 124(2):394-401. PubMed ID: 18814262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health-related quality of life in head and neck cancer survivors: impact of pretreatment depressive symptoms.
    Howren MB; Christensen AJ; Karnell LH; Funk GF
    Health Psychol; 2010 Jan; 29(1):65-71. PubMed ID: 20063937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subsite-specific trends in mid- and long-term survival for head and neck cancer patients in Japan: A population-based study.
    Tsuge H; Kawakita D; Taniyama Y; Oze I; Koyanagi YN; Hori M; Nakata K; Sugiyama H; Miyashiro I; Oki I; Nishino Y; Katanoda K; Ito Y; Shibata A; Matsuda T; Iwasaki S; Matsuo K; Ito H
    Cancer Sci; 2024 Feb; 115(2):623-634. PubMed ID: 37994633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disparities in head and neck cancer: assessing delay in treatment initiation.
    Patel UA; Brennan TE
    Laryngoscope; 2012 Aug; 122(8):1756-60. PubMed ID: 22570084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of delay in diagnosis on survival to head and neck carcinomas: a systematic review with meta-analysis.
    Seoane J; Takkouche B; Varela-Centelles P; Tomás I; Seoane-Romero JM
    Clin Otolaryngol; 2012 Apr; 37(2):99-106. PubMed ID: 22429704
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk of head and neck cancer in patients with diabetes mellitus: a retrospective cohort study in Taiwan.
    Tseng KS; Lin C; Lin YS; Weng SF
    JAMA Otolaryngol Head Neck Surg; 2014 Aug; 140(8):746-53. PubMed ID: 25058016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relative importance of diagnostic delays in different head and neck cancers.
    Teppo H; Alho OP
    Clin Otolaryngol; 2008 Aug; 33(4):325-30. PubMed ID: 18983341
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence trends of human papillomavirus-related head and neck cancer in Taiwan, 1995-2009.
    Hwang TZ; Hsiao JR; Tsai CR; Chang JS
    Int J Cancer; 2015 Jul; 137(2):395-408. PubMed ID: 25395239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ten-year retrospective study of head and neck carcinoma in situ: incidence, treatment, and clinical outcome.
    Christensen A; Kristensen E; Therkildsen MH; Specht L; Reibel J; Homøe P
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):174-8. PubMed ID: 23643320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factor profiles of head and neck cancer patients of Andhra Pradesh, India.
    Addala L; Pentapati CK; Reddy Thavanati PK; Anjaneyulu V; Sadhnani MD
    Indian J Cancer; 2012; 49(2):215-9. PubMed ID: 23107973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database.
    Carvalho AL; Nishimoto IN; Califano JA; Kowalski LP
    Int J Cancer; 2005 May; 114(5):806-16. PubMed ID: 15609302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic Sinusitis and Risk of Head and Neck Cancer in the US Elderly Population.
    Beachler DC; Engels EA
    JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):25-31. PubMed ID: 27606895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Remaining problems and controversies in the management of childhood head and neck soft tissue sarcomas: Retrospective (national) Multicenter Study of the Polish Pediatric Solid Tumors Group.
    Kazanowska B; Reich A; Reich M; Balcerska A; Balwierz W; Bodalski J; Dłuzniewska A; Drozyńska E; Katski K; Kijowski J; Kowalczyk J; Kurylak A; Matysiak M; Mikołajewska A; Peregut-Pogorzelski J; Sopyło B; Stencel D; Szewczyk B; Wachowiak J; Wieczorek M; Wysocki M; Chybicka A;
    Pediatr Hematol Oncol; 2004 Jun; 21(4):349-62. PubMed ID: 15205098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral lesions, chronic diseases and the risk of head and neck cancer.
    Li S; Lee YC; Li Q; Chen CJ; Hsu WL; Lou PJ; Zhu C; Pan J; Shen H; Ma H; Cai L; He B; Wang Y; Zhou X; Ji Q; Zhou B; Wu W; Ma J; Boffetta P; Zhang ZF; Dai M; Hashibe M
    Oral Oncol; 2015 Dec; 51(12):1082-7. PubMed ID: 26526128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.